Dr Reddys Laboratories Share Price Today - Live Blog for October 10, 2025

With a -0.03% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,264.60. Investors should examine the factors driving this decline. The stock's PE ratio is 18.1000, whereas the industry PE ratio stands at 34.3195.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.11%, signalling a challenging period. Currently trading at ₹1,263.40, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.04% upswing and is currently trading at ₹1,264.25, indicating strong market sentiment.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.03%, reaching a current market price of ₹1,263.80. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.27%. At this moment, it's actively trading at ₹1,264.35, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd's stock showed no movement, maintaining its position at ₹1,261.00. The stock has a PE ratio of 18.1000, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd observed a -0.04% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,261.55. The stock has a PE ratio of 18.1000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares experienced a -0.07% reduction, with the current market price at ₹1,262.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd experienced a -0.02% dip in its share price and is currently trading at ₹1,262.35. The stock has a PE ratio of 18.1000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has dropped by -0.16%, a development that warrants careful analysis. Presently trading at ₹1,259.70, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd witnessed a -0.11% drop in its share price and is currently trading at ₹1,263.00. With the stock's PE at 18.1000 and the industry PE at 34.3195, investors are weighing their options.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.11% in its share price, and it currently trades at ₹1,263.00 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares experienced a -0.11% reduction, with the current market price at ₹1,263.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

With a -0.16% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,264.35. Investors should examine the factors driving this decline. The stock's PE ratio is 18.1000, whereas the industry PE ratio stands at 34.3195.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.16% in its share price, and it currently trades at ₹1,264.35 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has fallen by -0.16%, a situation worth noting. At present, the stock is trading at ₹1,264.35. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.1000, while the industry PE ratio is 34.3195.

Dr Reddys Laboratories Ltd experienced a -0.11% dip in its share price and is currently trading at ₹1,262.40. The stock has a PE ratio of 18.1000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.11%, signalling a challenging period. Currently trading at ₹1,262.40, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Dr Reddys Laboratories Ltd remained stagnant, with no fluctuations. It is currently at ₹1,263.80. Investors may use this stability as an opportunity to reevaluate their portfolios and risk tolerance.

Dr Reddys Laboratories Ltd's share price remained steady, showing no variations, and is currently at ₹1,263.80. While the stock's performance remains consistent, it's worth noting that its PE ratio is 18.1000, while the industry PE is 34.3195.

Dr Reddys Laboratories Ltd stock stayed at its current value, with no movement, and is trading at ₹1,263.80. The stock has a PE ratio of 18.1000, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd showed no price fluctuations, keeping steady at ₹1,263.80. While the stock's performance remains consistent, it's worth noting that its PE ratio is 18.1000, while the industry PE is 34.3195.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.06% uptick in its share price. As a result, it's now actively trading at ₹1,262.40 per share, making it an attractive option for investors.

With a remarkable 0.38% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,262.60. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.1000, while the industry's PE ratio is 34.3195.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.14%, reaching the current market price of ₹1,252.80. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd witnessed a substantial 0.14% increase in its share price and is currently trading at ₹1,252.80. This remarkable performance has caught the eye of investors.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.12%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,251.85 per share.

With a -0.48% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,250.45. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.1000, while the industry PE is 34.3195.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.04% drop, and it's now trading at ₹1,256.45 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.11%. At this moment, it's actively trading at ₹1,256.35, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd experienced a substantial 0.45% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,255.45, making it an appealing option for investors.

Dr Reddys Laboratories Ltd's stock price surged by 0.18%, reaching the current market value of ₹1,247.90 per share. This surge is a testament to the stock's recent performance.